You are here

PloS one DOI:10.1371/journal.pone.0020351

Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer.

Publication TypeJournal Article
Year of Publication2011
AuthorsDutt, A, Ramos, AH, Hammerman, PS, Mermel, C, Cho, J, Sharifnia, T, Chande, A, Tanaka, KE, Stransky, N, Greulich, H, Gray, NS, Meyerson, M
JournalPloS one
Volume6
Issue6
Pagese20351
Date Published2011/01/01
Abstract

Squamous cell lung carcinomas account for approximately 25% of new lung carcinoma cases and 40,000 deaths per year in the United States. Although there are multiple genomically targeted therapies for lung adenocarcinoma, none has yet been reported in squamous cell lung carcinoma.

URLhttp://dx.plos.org/10.1371/journal.pone.0020351
DOI10.1371/journal.pone.0020351
Pubmed

http://www.ncbi.nlm.nih.gov/pubmed/21666749?dopt=Abstract